Model
Edge
Titan Pharmaceuticals Inc
TTNP
Filing Type
8-K
Filing Date
3/31/2025
Updated
4/1/25, 2:05 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation
EX-4.1
EXHIBIT 4.1
EX-10.1
EXHIBIT 10.1
EX-10.2
EXHIBIT 10.2